{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:49:46Z","timestamp":1788306586973,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009340","name":"Children's Discovery Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009340","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaip.2020.11.055","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T22:19:48Z","timestamp":1612563588000},"page":"628-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lifelong Immune Modulation Versus Hematopoietic Cell Therapy for Inborn Errors of Immunity"],"prefix":"10.1016","volume":"9","author":[{"given":"Megan A.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Nataraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.11.055_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smim.2017.12.008","article-title":"Human genetics of infectious diseases: unique insights into immunological redundancy","volume":"36","author":"Casanova","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.smim.2017.12.001","article-title":"What do primary immunodeficiencies tell us about the essentiality\/redundancy of immune responses?","volume":"36","author":"Fischer","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.coi.2019.03.008","article-title":"Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism","volume":"59","author":"Zhang","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaci.2018.09.009","article-title":"Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases","volume":"143","author":"Mensa-Vilaro","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","article-title":"Primary immunodeficiencies: 2009 update","volume":"124","author":"Notarangelo","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib9","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","article-title":"Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/hum.2017.005","article-title":"CRISPR-mediated knockout of Cybb in NSG mice establishes a model of chronic granulomatous disease for human stem-cell gene therapy transplants","volume":"28","author":"Sweeney","year":"2017","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jaip.2020.11.055_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jpeds.2009.07.049","article-title":"Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis","volume":"155","author":"Railey","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2020.11.055_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-010-8191-9","article-title":"Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: long-term outcomes","volume":"49","author":"Buckley","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaip.2020.11.055_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199902183400703","article-title":"Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"340","author":"Buckley","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.V99.3.872","article-title":"Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival","volume":"99","author":"Myers","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib18","first-page":"3646","article-title":"Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients","volume":"91","author":"Haddad","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.11.055_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2020.11.055_bib21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib22","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/pbc.25554","article-title":"Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia","volume":"62","author":"Abu-Arja","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaip.2020.11.055_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13045-016-0240-y","article-title":"Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity","volume":"9","author":"Ikegame","year":"2016","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.jaip.2020.11.055_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib25","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood-2009-12-234096","article-title":"Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update","volume":"115","author":"Seggewiss","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbmt.2008.11.024","article-title":"Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and IgM memory B cells","volume":"15","author":"D\u2019Orsogna","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaip.2020.11.055_bib27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency","volume":"135","author":"Wehr","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib28","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2010-03-275966","article-title":"Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly","volume":"116","author":"Janda","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib29","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jaci.2007.08.048","article-title":"Long-term results of bone marrow transplantation in complete DiGeorge syndrome","volume":"120","author":"Land","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-2141.2002.03496.x","article-title":"T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome","volume":"117","author":"Bensoussan","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2020.11.055_bib31","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1542\/peds.2005-0371","article-title":"Complete DiGeorge anomaly in the absence of neonatal hypocalcemia and velofacial and cardiac defects","volume":"116","author":"Al-Tamemi","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2020.11.055_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.4237","article-title":"Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids","volume":"14","author":"Seet","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaip.2020.11.055_bib33","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2002-08-2545","article-title":"Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients","volume":"102","author":"Markert","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib34","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2017.03.020","article-title":"Thymus transplantation for complete DiGeorge syndrome: European experience","volume":"140","author":"Davies","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaip.2020.11.055_bib36","doi-asserted-by":"crossref","first-page":"e88782","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2020.11.055_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12714","article-title":"Lessons from primary immunodeficiencies: autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"287","author":"Constantine","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2020.11.055_bib38","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib39","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus","volume":"360","author":"Reddy","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archdermatol.2011.2857","article-title":"Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: excellent response to anakinra","volume":"148","author":"Brau-Javier","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2020.11.055_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13223-018-0290-5","article-title":"Primary immunodeficiency","volume":"14","author":"McCusker","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10875-014-0029-0","article-title":"The Case for mandatory newborn screening for severe combined immunodeficiency (SCID)","volume":"34","author":"Gaspar","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib43","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib44","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1586\/1744666X.2015.1062366","article-title":"Current and emerging treatment options for Wiskott-Aldrich syndrome","volume":"11","author":"Worth","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2012.09.025","article-title":"Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation","volume":"131","author":"Engelhardt","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib46","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1203\/00006450-199333011-00009","article-title":"Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and Case reports of three patients, including two now receiving gene therapy","volume":"33","author":"Hershfield","year":"1993","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaip.2020.11.055_bib47","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A\u00a0controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group","volume":"324","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib49","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib50","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3389\/fimmu.2018.02043","article-title":"The treatment of activated PI3Kdelta syndrome","volume":"9","author":"Coulter","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib51","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib52","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaip.2016.08.004","article-title":"Mechanism-based strategies for the management of autoimmunity and immune dysregulation in primary immunodeficiencies","volume":"4","author":"Walter","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.11.055_bib53","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2019.11.043","article-title":"Treatment with rapamycin can restore regulatory T-cell function in IPEX patients","volume":"145","author":"Passerini","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2020.03.043","article-title":"HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency","volume":"146","author":"Prunotto","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib55","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2010-08-303263","article-title":"Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients","volume":"117","author":"Smith","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib56","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2012-09-455063","article-title":"How I assess comorbidities before hematopoietic cell transplantation","volume":"121","author":"Sorror","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/eci.12.9","article-title":"Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies","volume":"8","author":"Chiesa","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib58","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/cancers12071974","article-title":"Reconstitution of T cell subsets following allogeneic hematopoietic cell transplantation","volume":"12","author":"Dekker","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaip.2020.11.055_bib59","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T\u00a0cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib60","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2352-3026(17)30104-7","article-title":"Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis","volume":"4","author":"Eapen","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jaip.2020.11.055_bib61","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.beha.2017.09.003","article-title":"Which factors influence the development of GVHD in HLA-matched or mismatched transplants?","volume":"30","author":"Petersdorf","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jaip.2020.11.055_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","article-title":"Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)","volume":"117","author":"Chan","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12997","article-title":"Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations","volume":"190","author":"Verma","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib64","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.jaip.2019.06.011","article-title":"Abatacept as a long-term targeted therapy for LRBA deficiency","volume":"7","author":"Kiykim","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.11.055_bib65","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jpedsurg.2004.07.020","article-title":"Thymic transplantation for complete DiGeorge syndrome: medical and surgical considerations","volume":"39","author":"Rice","year":"2004","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jaip.2020.11.055_bib66","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrg3978","article-title":"Knocking down disease: a progress report on siRNA therapeutics","volume":"16","author":"Wittrup","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jaip.2020.11.055_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ebiom.2018.04.003","article-title":"Targeted protein degradation: unlocking the therapeutic proteome","volume":"30","author":"EbioMedicine","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaip.2020.11.055_bib68","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein degradation: expanding the toolbox","volume":"18","author":"Schapira","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaip.2020.11.055_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/bloodadvances.2018025858","article-title":"Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections","volume":"3","author":"Lounder","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2020.11.055_bib70","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/ACI.0000000000000396","article-title":"NLRC4 inflammasomopathies","volume":"17","author":"Romberg","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib71","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1093\/hmg\/ddz170","article-title":"Gene therapy for primary immunodeficiency","volume":"28","author":"Booth","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaip.2020.11.055_bib72","doi-asserted-by":"crossref","first-page":"737","DOI":"10.15252\/emmm.201707573","article-title":"Gene therapy for ADA-SCID, the first marketing approval of an ex\u00a0vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products","volume":"9","author":"Aiuti","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jaip.2020.11.055_bib73","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/mt.2016.148","article-title":"CRISPR\/Cas9-mediated correction of the sickle mutation in human CD34+ cells","volume":"24","author":"Hoban","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaip.2020.11.055_bib74","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood-2017-10-811505","article-title":"Induction of fetal hemoglobin synthesis by CRISPR\/Cas9-mediated editing of the human beta-globin locus","volume":"131","author":"Antoniani","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib75","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaci.2016.01.045","article-title":"Hematopoietic stem cell transplantation for CTLA4 deficiency","volume":"138","author":"Slatter","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib76","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-015-0187-8","article-title":"The ying and yang of STAT3 in human disease","volume":"35","author":"Vogel","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib77","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.11.055_bib78","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jaci.2019.12.896","article-title":"Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score","volume":"145","author":"Tesch","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib79","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jaci.2017.11.042","article-title":"Mutations in PI3K110delta cause impaired natural killer cell function partially rescued by rapamycin treatment","volume":"142","author":"Ruiz-Garcia","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib80","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10875-014-0012-9","article-title":"Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility","volume":"34","author":"Crank","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib81","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3389\/fimmu.2018.01758","article-title":"Genetic defects in phosphoinositide 3-kinase delta influence CD8(+) T cell survival, differentiation, and function","volume":"9","author":"Cannons","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib82","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jaip.2020.11.055_bib83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2020.11.055_bib84","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood.2019002072","article-title":"Increased activation of PI3 kinase-delta predisposes to B-cell lymphoma","volume":"135","author":"Durandy","year":"2020","journal-title":"Blood"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820313295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820313295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:27:13Z","timestamp":1761974833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820313295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213219820313295"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.11.055","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifelong Immune Modulation Versus Hematopoietic Cell Therapy for Inborn Errors of Immunity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.11.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}